C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2002
12/05/2002	WO2002096424A1 Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents
12/05/2002	WO2002096420A2 Method for treating nerve injury caused by surgery
12/05/2002	WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002	US20020183361 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183317 Administering thiazole compound for therapy of fibrotic diseases
12/05/2002	DE10125963A1 Substituierte Imidate Substituted Imidates
12/05/2002	CA2449019A1 Method for treating nerve injury caused by surgery
12/05/2002	CA2448205A1 Oxazol/thiazol-derivatives activators of the hppar-alpha receptor
12/05/2002	CA2448160A1 Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
12/05/2002	CA2448103A1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
12/05/2002	CA2448101A1 Process for preparing a thialzole ppar-ligand and polymorphs thereof
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	CA2445647A1 1,3-dihydroxybenzene derivatives and colorants containing said compounds
12/05/2002	CA2411549A1 Ligands of integrin receptors
12/04/2002	EP1262177A2 Medical use of thyromimetic compounds to treat hair loss and compositions
12/04/2002	EP1261607A1 2,4-disubstituted thiazolyl derivatives
12/04/2002	EP1261599A1 Dyes for keratin fibres containing 1,3-diamino-4-heteroarylbenzene derivatives and novel 1,3-diamino-4-heteroarylbenzene derivatives
12/04/2002	EP1261593A1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1111993A4 Fused-benzene derivatives useful as herbicides
12/04/2002	EP1005342B1 Pharmaceutical compositions of tizoxanide and nitazoxanide
12/04/2002	EP0907650B1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines
12/03/2002	US6489485 Para-amine substituted phenylamide glucokinase activators
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002	CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002	WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002	WO2002094798A1 Process for preparation of thiazole compounds
11/28/2002	WO2002094770A2 Aminoalcohol derivatives
11/28/2002	WO2002094768A2 Aza hydroxylated ethyl amine compounds
11/28/2002	WO2002094264A1 Ccr4 antagonists
11/28/2002	WO2002048106A3 Isoindolin-1-one glucokinase activators
11/28/2002	US20020177622 Neuroprotectants; enhancing cognition
11/28/2002	US20020177595 Novel compounds useful as neuro-protective agents
11/28/2002	US20020177594 Inhibitors of histone deacetylase
11/28/2002	US20020177586 Method for treating fibrotic diseases or other indications ID
11/28/2002	DE10125432A1 New benzoyl-substituted aliphatic ketones or aldehydes, useful as herbicides or fungicides, especially as pre- and post-emergence selective herbicides against a broad spectrum of weeds
11/28/2002	CA2448084A1 Aza hydroxylated ethyl amine compounds
11/27/2002	EP1259498A1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
11/27/2002	EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists
11/27/2002	EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof
11/27/2002	EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them
11/27/2002	CN1382131A Substituted benzylthiazolidine-2,4-dione derivatives
11/27/2002	CN1382130A Substituted benzylthiazolidine-2,4-dione derivatives
11/27/2002	CN1382129A Substituted benzylthiazolidine-2,4-dione derivatives
11/27/2002	CN1382128A Substituted benzylthiazolidine-2,4-dione derivatives
11/27/2002	CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002	CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/26/2002	US6486194 Alzheimer's disease
11/26/2002	US6486187 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
11/26/2002	US6486184 1-(cyclopentyloxy-(3,4-dichloro- phenyl)-acetyl)-3-methyl-urea for example; use in treating hyperglycemia characteristic of all type ii diabetes
11/26/2002	US6486159 Water soluble prodrugs of azole compounds
11/25/2002	WO2001090087A1 Heterocyclic compounds
11/25/2002	CA2410382A1 Heterocyclic compounds
11/21/2002	WO2002092583A1 Ether carboxylic acids based on alkoxylated mercaptobenzothiazole and the use of the same as corrosion inhibitors
11/21/2002	WO2002092582A1 Protease-inhibitors
11/21/2002	WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	WO2002058532A3 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
11/21/2002	WO2002028841B1 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/21/2002	WO2002012250B1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
11/21/2002	US20020173631 4-((5,5-dimethyl-5,6,7,8-tetrahydro-8-hydroxynaphthalen-2 -yl)carbonyloxy)benzoic acid, benzyl ester for example; receptor subtype selectivity for side effect reduction
11/21/2002	US20020173524 Modulation of CCR4 function
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173469 Protease inhibitors
11/21/2002	DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002	DE10135549A1 New 4-heterocyclyl-1-benzyloxybenzene derivatives, useful as pesticides for plant protection and preservation of technical products, and as intermediates for active compounds
11/21/2002	DE10124041A1 New peptide-type compounds, useful as protease, especially thrombin, inhibitors for treating e.g. thrombosis and cardiac infarct
11/21/2002	CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/20/2002	EP1258491A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2002	EP1258476A1 Alpha-amino acid derivatives, method for their preparation and their use as dipeptidyl-peptidase IV inhibitors (DPP IV)
11/20/2002	EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002	EP1257271A1 Use of pramipexole for the treatment of addictive disorders
11/20/2002	EP1257265A2 Use of 2-phenylene diamine derivatives for the treatment of infections
11/20/2002	EP1165472A4 Methods for the preparation of biphenyl isoxazole sulfonamides
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482859 Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives
11/19/2002	US6482814 Biocidal composition and its use
11/19/2002	CA2090091C Process for sulfenimides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090331A1 Method for producing 1,3-disubstituted 2-nitroguanidines
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002	US20020169325 Useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia, atherosclerosis, gastrointestinal disorders
11/14/2002	US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
11/14/2002	US20020169185 Quinolinyl and benzothiazolyl modulators
11/14/2002	DE10122539A1 Mehrzähnige unsymmetrische Liganden auf Binaphthylbasis Multidentate unsymmetrical ligands on Binaphthylbasis

1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 337